The Therapeutic Potential of FLASH-RT for Pancreatic Cancer

15Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.

Abstract

Recent preclinical evidence has shown that ionizing radiation given at an ultra-high dose rate (UHDR), also known as FLASH radiation therapy (FLASH-RT), can selectively reduce radiation injury to normal tissue while remaining isoeffective to conventional radiation therapy (CONV-RT) with respect to tumor killing. Unresectable pancreatic cancer is challenging to control without ablative doses of radiation, but this is difficult to achieve without significant gastrointestinal toxicity. In this review article, we explore the propsed mechanisms of FLASH-RT and its tissue-sparing effect, as well as its relevance and suitability for the treatment of pancreatic cancer. We also briefly discuss the challenges with regard to dosimetry, dose rate, and fractionation for using FLASH-RT to treat this disease.

Cite

CITATION STYLE

APA

Okoro, C. M., Schüler, E., & Taniguchi, C. M. (2022). The Therapeutic Potential of FLASH-RT for Pancreatic Cancer. Cancers, 14(5). https://doi.org/10.3390/cancers14051167

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free